The Role of Venture Capital In Biotech and Real Estate Expansion

The Role of Venture Capital In Biotech and Real Estate Expansion

Sometimes the person across the table has a fund thesis that sounds, on the surface, like it shouldn’t concern me with all those deep tech, life sciences, climate-adjacent bets. And then halfway through, they start asking about buildings. Not because they want to invest in construction. Because they’ve realised that the companies they’ve already backed […]

How Biotech Growth Is Reshaping Commercial Property Demand

How Biotech Growth Is Reshaping Commercial Property Demand

The way biotech is growing in terms of the speed, the scale, the kind of infrastructure it demands is creating a very specific and very underserved pressure on commercial real estate. And most developers haven’t noticed yet. I have. Because I’m living inside both industries at the same time. Biotech Doesn’t Just Need Office Space. […]

The biggest trends shaping biotech in 2026

The biggest trends shaping biotech in 2026

I didn’t come from biotech. I’ll say that upfront. My background is in real estate. I build homes. I think about spaces, communities, the way design makes people feel. And then one evening in Goa, mid-conversation with a friend, a stranger overheard us and introduced me to Dr. Murugan Paramasivam and his work on PHA, […]

The Impact of Remote Work on Office Space Demand

The Impact of Remote Work on Office Space Demand

I travel a lot. Not just for business but also for me as I believe that travel is where ideas breathe. You step out of your routine, your eyes land on something new, and suddenly a problem you’ve been sitting with for months cracks open. Some of my biggest decisions were made not in boardrooms […]

The Real Estate Needs of Biotech Companies

The Real Estate Needs of Biotech Companies

I have been on both sides of this problem, which is a position I did not plan for and have come to appreciate more than almost anything else about how my career has unfolded. On one side, I build real estate in which I know how buildings are designed, priced, leased, and what landlords think […]

How “The Titan Story” Changed the Way I Think About Business and Leadership

When I pressed play, I didn’t get up until it was over. Six episodes, one sitting. That’s when I knew this one was worth my time. “Made in India: A Titan Story” was about an Indian who set out to make something the world said couldn’t be made here, and as someone who builds for […]

Why sustainable buildings are becoming the new standard

Why sustainable buildings are becoming the new standard

For most of my career in real estate, sustainability was a conversation I had after the important conversations were finished. After the land cost, the FSI calculations, the sales velocity projections, the bank’s sanction letter. After all of that, someone would mention GRIHA or LEED, and we would figure out how much of it we […]

real estate and biotech

Lessons I’ve learned leading two different industries

Nobody told me that running two companies would be less like juggling and more like speaking two languages simultaneously. I built Techton Life Spaces first. Real estate is a world of physical certainty where you have a land you can walk on, concrete you can touch, a date on a possession letter you can hold […]

Building spaces for the future of research and innovation

Building spaces for the future of research and innovation

I find genuinely difficult to describe to people who have not experienced it that the feeling that the space itself is a participant in the work. The layout matters. The airflow matters. The distance between the lab bench and the storage area, the quality of the flooring, the placement of the ventilation all of it […]

Why personalized medicine is gaining attention

Why personalized medicine is gaining attention

I’ve seen people go through a cancer diagnosis and honestly it changed how I think about medicine entirely. The oncologist ordered a genomic panel. Two weeks later, the results came back showing a specific mutation that ruled out the standard first-line treatment, the one most patients with that diagnosis receive and pointed toward a targeted […]